CompletedNot Applicable

A Prospective Controlled Study on Treatment of Giant Cavernous Hemangiomas of the Liver

China140 participantsStarted 2011-11

Plain-language summary

In the past, the investigators often treated giant cavernous hemangiomas of the liver by hepatectomy.Recently RFA and laparoscopic hepatectomy are also available and could be applied to cure this disease.But we can't get a clear answer about their effectiveness and safety. Hence the investigators conduct this study to explore the effectiveness and efficiency of the these two methods and compare their short to mid-term outcomes.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * giant cavernous hemangiomas with a diameter larger than or equal to 5 cm diagnosed by more than one imaging modalities * age between 18 years to 65 years * without gender restriction * PLT account more than 50 e9 * without abnormal of liver function test * with substantial evidence of growing size than before * symptom associated cavernous hemangiomas * with a strong desire of the patients for the treatment Exclusion Criteria: * pregnant women * abnormal of liver function or coagulation dysfunction and/or concurrent with sever cardiac or pulmonary disorders * patient with a poor condition that can't bear the approach of either RFA or laparoscopic hepatectomy * tumor size more than 20cm

What they're measuring

disappearance rate of disease

Timeframe: 1 month

Trial details

NCT IDNCT01471080

SponsorSouthwest Hospital, China

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2013-10

View on ClinicalTrials.gov More Laparoscopic Hepatectomy trials